Abstract
Despite the remarkable advances in cardiovascular therapeutics over the past four decades, little impact has been made on either the incidence or mortality rate of congestive heart failure and it remains a major clinical and public health problem. Recent practice audits have suggested that proven efficacious therapies are not maximally applied in patients with this condition. An approach to the patient with congestive heart failure is presented, emphasizing the two distinct syndromes of systolic dysfunction and diastolic dysfunction. Treatment recommendations are derived from consideration of the underlying pathophysiology and the evidence from randomised clinical trials.
Full text
PDF






Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alderman E. L., Fisher L. D., Litwin P., Kaiser G. C., Myers W. O., Maynard C., Levine F., Schloss M. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation. 1983 Oct;68(4):785–795. doi: 10.1161/01.cir.68.4.785. [DOI] [PubMed] [Google Scholar]
- Bourassa M. G., Gurné O., Bangdiwala S. I., Ghali J. K., Young J. B., Rousseau M., Johnstone D. E., Yusuf S. Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators. J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):14A–19A. doi: 10.1016/0735-1097(93)90456-b. [DOI] [PubMed] [Google Scholar]
- Cohn J. N., Archibald D. G., Ziesche S., Franciosa J. A., Harston W. E., Tristani F. E., Dunkman W. B., Jacobs W., Francis G. S., Flohr K. H. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Jun 12;314(24):1547–1552. doi: 10.1056/NEJM198606123142404. [DOI] [PubMed] [Google Scholar]
- Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
- Doval H. C., Nul D. R., Grancelli H. O., Perrone S. V., Bortman G. R., Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) Lancet. 1994 Aug 20;344(8921):493–498. doi: 10.1016/s0140-6736(94)91895-3. [DOI] [PubMed] [Google Scholar]
- Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med. 1991 Aug 1;325(5):293–302. doi: 10.1056/NEJM199108013250501. [DOI] [PubMed] [Google Scholar]
- Feldman A. M., Bristow M. R., Parmley W. W., Carson P. E., Pepine C. J., Gilbert E. M., Strobeck J. E., Hendrix G. H., Powers E. R., Bain R. P. Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. N Engl J Med. 1993 Jul 15;329(3):149–155. doi: 10.1056/NEJM199307153290301. [DOI] [PubMed] [Google Scholar]
- Furberg C. D., Psaty B. M., Meyer J. V. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation. 1995 Sep 1;92(5):1326–1331. doi: 10.1161/01.cir.92.5.1326. [DOI] [PubMed] [Google Scholar]
- Goldsmith S. R., Dick C. Differentiating systolic from diastolic heart failure: pathophysiologic and therapeutic considerations. Am J Med. 1993 Dec;95(6):645–655. doi: 10.1016/0002-9343(93)90361-r. [DOI] [PubMed] [Google Scholar]
- Ho K. K., Pinsky J. L., Kannel W. B., Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):6A–13A. doi: 10.1016/0735-1097(93)90455-a. [DOI] [PubMed] [Google Scholar]
- Johnstone D. E., Abdulla A., Arnold J. M., Bernstein V., Bourassa M., Brophy J., Davies R., Gardner M., Hoeschen R., Mickleborough L. Diagnosis and management of heart failure. Canadian Cardiovascular Society. Can J Cardiol. 1994 Jul-Aug;10(6):613-31, 635-54. [PubMed] [Google Scholar]
- Packer M., Carver J. R., Rodeheffer R. J., Ivanhoe R. J., DiBianco R., Zeldis S. M., Hendrix G. H., Bommer W. J., Elkayam U., Kukin M. L. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991 Nov 21;325(21):1468–1475. doi: 10.1056/NEJM199111213252103. [DOI] [PubMed] [Google Scholar]
- Packer M., O'Connor C. M., Ghali J. K., Pressler M. L., Carson P. E., Belkin R. N., Miller A. B., Neuberg G. W., Frid D., Wertheimer J. H. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med. 1996 Oct 10;335(15):1107–1114. doi: 10.1056/NEJM199610103351504. [DOI] [PubMed] [Google Scholar]
- Parameshwar J., Shackell M. M., Richardson A., Poole-Wilson P. A., Sutton G. C. Prevalence of heart failure in three general practices in north west London. Br J Gen Pract. 1992 Jul;42(360):287–289. [PMC free article] [PubMed] [Google Scholar]
- Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
- Psaty B. M., Heckbert S. R., Koepsell T. D., Siscovick D. S., Raghunathan T. E., Weiss N. S., Rosendaal F. R., Lemaitre R. N., Smith N. L., Wahl P. W. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 1995 Aug 23;274(8):620–625. [PubMed] [Google Scholar]
- Singh S. N., Fletcher R. D., Fisher S. G., Singh B. N., Lewis H. D., Deedwania P. C., Massie B. M., Colling C., Lazzeri D. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med. 1995 Jul 13;333(2):77–82. doi: 10.1056/NEJM199507133330201. [DOI] [PubMed] [Google Scholar]
- Swedberg K., Held P., Kjekshus J., Rasmussen K., Rydén L., Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med. 1992 Sep 3;327(10):678–684. doi: 10.1056/NEJM199209033271002. [DOI] [PubMed] [Google Scholar]
- Teo K. K., Ignaszewski A. P., Gutierrez R., Hill K. L., Martin S. L., Calhoun H. P., Humen D. P., Montague T. J. Contemporary medical management of left ventricular dysfunction and congestive heart failure. Can J Cardiol. 1992 Jul-Aug;8(6):611–619. [PubMed] [Google Scholar]
- Uren N. G., Lipkin D. P. Exercise training as therapy for chronic heart failure. Br Heart J. 1992 Jun;67(6):430–433. doi: 10.1136/hrt.67.6.430. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Uretsky B. F., Young J. B., Shahidi F. E., Yellen L. G., Harrison M. C., Jolly M. K. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol. 1993 Oct;22(4):955–962. doi: 10.1016/0735-1097(93)90403-n. [DOI] [PubMed] [Google Scholar]
- Waagstein F., Bristow M. R., Swedberg K., Camerini F., Fowler M. B., Silver M. A., Gilbert E. M., Johnson M. R., Goss F. G., Hjalmarson A. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet. 1993 Dec 11;342(8885):1441–1446. doi: 10.1016/0140-6736(93)92930-r. [DOI] [PubMed] [Google Scholar]
